JP2009522368A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009522368A5 JP2009522368A5 JP2008549583A JP2008549583A JP2009522368A5 JP 2009522368 A5 JP2009522368 A5 JP 2009522368A5 JP 2008549583 A JP2008549583 A JP 2008549583A JP 2008549583 A JP2008549583 A JP 2008549583A JP 2009522368 A5 JP2009522368 A5 JP 2009522368A5
- Authority
- JP
- Japan
- Prior art keywords
- hcv
- agent
- composition
- complex
- nucleic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US75635406P | 2006-01-04 | 2006-01-04 | |
| US60/756,354 | 2006-01-04 | ||
| US79984006P | 2006-05-11 | 2006-05-11 | |
| US60/799,840 | 2006-05-11 | ||
| US84008206P | 2006-08-25 | 2006-08-25 | |
| US60/840,082 | 2006-08-25 | ||
| PCT/US2007/000362 WO2007081848A2 (en) | 2006-01-04 | 2007-01-04 | Activation of hcv-specific t cells |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2009522368A JP2009522368A (ja) | 2009-06-11 |
| JP2009522368A5 true JP2009522368A5 (https=) | 2011-02-10 |
| JP5405832B2 JP5405832B2 (ja) | 2014-02-05 |
Family
ID=38256946
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008549583A Expired - Fee Related JP5405832B2 (ja) | 2006-01-04 | 2007-01-04 | Ｈｃｖ特異的なｔ細胞の活性化 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US8178086B2 (https=) |
| EP (1) | EP1981537B1 (https=) |
| JP (1) | JP5405832B2 (https=) |
| CA (1) | CA2636032C (https=) |
| ES (1) | ES2551113T3 (https=) |
| WO (1) | WO2007081848A2 (https=) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101578520B (zh) | 2006-10-18 | 2015-09-16 | 哈佛学院院长等 | 基于形成图案的多孔介质的横向流动和穿过生物测定装置、及其制备方法和使用方法 |
| CA2719800A1 (en) | 2008-03-27 | 2009-10-01 | President And Fellows Of Harvard College | Paper-based microfluidic systems |
| AU2009228014B2 (en) | 2008-03-27 | 2014-10-02 | President And Fellows Of Harvard College | Cotton thread as a low-cost multi-assay diagnostic platform |
| EP2265959B1 (en) | 2008-03-27 | 2014-03-05 | President and Fellows of Harvard College | Paper-based cellular arrays |
| CN102016595B (zh) | 2008-03-27 | 2014-08-06 | 哈佛学院院长等 | 三维微流体装置 |
| ES2612507T3 (es) | 2009-03-06 | 2017-05-17 | President And Fellows Of Harvard College | Dispositivos microfluídicos y electroquímicos |
| CU24112B1 (es) * | 2012-11-05 | 2015-08-27 | Ct De Ingeniería Genética Y Biotecnología | Antígenos vacunales quiméricos contra el virus de la hepatitis c |
| RU2675108C2 (ru) * | 2015-06-15 | 2018-12-17 | Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт биомедицинской химии имени В.Н. Ореховича" (ИБМХ) | Композиция на основе синтетических пептидов и липидов для вакцины против гепатита с |
| EP4516312A3 (en) | 2015-07-07 | 2025-04-30 | The Governors Of The University Of Alberta | Hepatitis c virus immunogenic compositions and methods of use thereof |
| EP3515483A4 (en) * | 2016-09-21 | 2020-12-16 | The Governors of the University of Alberta | HEPATITIS C VIRUS IMMUNOGENIC COMPOSITIONS AND THEIR USE PROCEDURES |
| US20240358821A1 (en) * | 2021-07-06 | 2024-10-31 | The Trustees Of The University Of Pennsylvania | P7 Containing Nucleoside-modified mRNA-lipid Nanoparticle Lineage Vaccine for Hepatitis C Virus |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6514731B1 (en) | 1996-05-24 | 2003-02-04 | Chiron Corporation | Methods for the preparation of hepatitis C virus multiple copy epitope fusion antigens |
| US6054424A (en) | 1998-04-15 | 2000-04-25 | Church & Dwight Co., Inc. | Process for the production of a liquid laundry detergent composition of desired viscosity containing nonionic and anionic surfactants |
| US20050074465A1 (en) | 1999-11-24 | 2005-04-07 | Michael Houghton | HCV fusion proteins with modified NS3 domains |
| JP2004500366A (ja) * | 1999-12-01 | 2004-01-08 | カイロン コーポレイション | Ｃ型肝炎ウイルス（ｈｃｖ）について特異的な抗体を誘発すること |
| US20030232324A1 (en) | 2001-05-31 | 2003-12-18 | Chiron Corporation | Chimeric alphavirus replicon particles |
| AU2002303330B2 (en) | 2001-05-31 | 2008-07-24 | Novartis Vaccines And Diagnostics, Inc. | Chimeric alphavirus replicon particles |
| GB0226722D0 (en) * | 2002-11-15 | 2002-12-24 | Glaxo Group Ltd | Vaccine |
| NZ551319A (en) | 2004-05-17 | 2010-07-30 | Novartis Vaccines & Diagnostic | Truncated Hepatitis C virus NS5 domain and fusion proteins comprising same |
-
2007
- 2007-01-04 EP EP07709585.9A patent/EP1981537B1/en not_active Not-in-force
- 2007-01-04 CA CA2636032A patent/CA2636032C/en not_active Expired - Fee Related
- 2007-01-04 ES ES07709585.9T patent/ES2551113T3/es active Active
- 2007-01-04 WO PCT/US2007/000362 patent/WO2007081848A2/en not_active Ceased
- 2007-01-04 JP JP2008549583A patent/JP5405832B2/ja not_active Expired - Fee Related
- 2007-01-04 US US12/087,330 patent/US8178086B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Lechmann et al. | Vaccine development for hepatitis C | |
| Encke et al. | DNA vaccines | |
| Bellier et al. | Virus-like particle-based vaccines against hepatitis C virus infection | |
| JP2009522368A5 (https=) | ||
| JP2006504644A5 (https=) | ||
| Vidalin et al. | Use of conventional or replicating nucleic acid-based vaccines and recombinant Semliki forest virus-derived particles for the induction of immune responses against hepatitis C virus core and E2 antigens | |
| Inchauspé et al. | Development of a hepatitis C virus vaccine | |
| JP2005510244A5 (https=) | ||
| Memarnejadian et al. | Fusion of HBsAg and prime/boosting augment Th1 and CTL responses to HCV polytope DNA vaccine | |
| AU2013339846B2 (en) | Chimeric vaccine antigens against hepatitis C virus | |
| CN110049993A (zh) | 组装的糖蛋白 | |
| Balakrishnan et al. | Discovery of HCV Vaccine: Where do we stand? | |
| US8691234B2 (en) | Vaccine formulation potentiated by the combination of DNA and an antigen | |
| CN101043902B (zh) | 针对丙型肝炎病毒的疫苗组合物 | |
| JPWO2021051153A5 (https=) | ||
| Zhu et al. | Induction of humoral and cellular immune responses against hepatitis C virus by vaccination with replicon particles derived from Sindbis-like virus XJ-160 | |
| Jahantigh et al. | Advancing peptide-based vaccines against viral pathogens: a narrative review | |
| Hill et al. | The Cellular Immune Response | |
| Kardani et al. | The next generation of HCV vaccines: a focus on novel adjuvant development | |
| Guan et al. | Effect of route of delivery on heterologous protection against HCV induced by an adenovirus vector carrying HCV structural genes | |
| Karayiannis et al. | Hepatitis vaccines | |
| Luo et al. | Recent advances in clinical trials of HCV vaccines | |
| Martin et al. | Hepatitis C vaccines | |
| Hynicka | State of the art of HCV vaccines in the era of new antivirals | |
| Saeedi et al. | Enhanced immune responses of a hepatitis C virus core DNA vaccine by co-inoculating interleukin-12 expressing vector in mice |